{
  "version": 1,
  "generatedAt": "2026-02-24T00:00:00Z",
  "categories": [
    "Cardiovascular Disorders",
    "Infectious Diseases",
    "Endocrinology",
    "Respiratory Disorders",
    "Renal & Electrolyte Disorders",
    "Gastrointestinal Disorders",
    "Neurology & Psychiatry",
    "Hematology",
    "Oncology",
    "Rheumatology & Pain",
    "Women's & Men's Health",
    "Immunizations",
    "Pharmacy Law & Ethics"
  ],
  "topics": [
    {
      "slug": "hypertension",
      "title": "Hypertension",
      "category": "Cardiovascular Disorders",
      "summary": "Blood pressure classification, first-line treatment, special populations, resistant hypertension, and hypertensive crisis.",
      "level": "core",
      "notePath": "hypertension.html",
      "tags": [
        "htn",
        "hpt",
        "high-blood-pressure",
        "acc-aha",
        "thiazide",
        "acei",
        "arb",
        "ccb",
        "resistant-hypertension"
      ],
      "sections": [
        { "id": "what-is-hypertension", "title": "What Is Hypertension?" },
        { "id": "primary-vs-secondary", "title": "Primary vs Secondary Hypertension" },
        { "id": "risk-factors", "title": "Risk Factors" },
        { "id": "complications", "title": "Complications" },
        { "id": "treatment-goals", "title": "Treatment Goals" },
        { "id": "lifestyle-management", "title": "Non-Pharmacologic Management" },
        { "id": "first-line-drug-classes", "title": "First-Line Drug Classes" },
        { "id": "special-populations", "title": "Special Populations" },
        { "id": "resistant-hypertension", "title": "Resistant Hypertension" },
        { "id": "hypertensive-crisis", "title": "Hypertensive Crisis" },
        { "id": "exam-traps", "title": "Common Exam Traps" },
        { "id": "quick-revision", "title": "Quick Revision Summary" }
      ]
    },
    {
      "slug": "heart-failure",
      "title": "Heart Failure",
      "category": "Cardiovascular Disorders",
      "summary": "HFrEF/HFpEF classification, four-pillar HFrEF therapy, acute decompensation, and exam traps.",
      "level": "core",
      "notePath": "heart-failure.html",
      "tags": [
        "gdmt",
        "hfrEF",
        "hfpef",
        "arni",
        "sglt2"
      ],
      "sections": [
        { "id": "what-is-heart-failure", "title": "What Is Heart Failure?" },
        { "id": "classification", "title": "Classification" },
        { "id": "pathophysiology", "title": "Pathophysiology" },
        { "id": "clinical-presentation", "title": "Clinical Presentation" },
        { "id": "hfrEF-four-pillars", "title": "HFrEF Four Foundational Pillars" },
        { "id": "additional-therapies", "title": "Additional Therapies" },
        { "id": "symptom-control", "title": "Symptom Control" },
        { "id": "acute-decompensated-hf", "title": "Acute Decompensated HF" },
        { "id": "exam-traps", "title": "Common Exam Traps" },
        { "id": "quick-revision", "title": "Quick Revision Summary" }
      ]
    },
    {
      "slug": "ischemic-heart-disease",
      "title": "Ischemic Heart Disease",
      "category": "Cardiovascular Disorders",
      "summary": "Stable angina vs ACS, antiplatelets, anticoagulants, reperfusion, and secondary prevention.",
      "level": "core",
      "notePath": "ischemic-heart-disease.html",
      "tags": [
        "ihd",
        "cad",
        "acs",
        "nstemi",
        "stemi",
        "dapt",
        "statin",
        "nitroglycerin"
      ],
      "sections": [
        { "id": "what-is-ihd", "title": "What Is Ischemic Heart Disease?" },
        { "id": "pathophysiology", "title": "Pathophysiology" },
        { "id": "clinical-classification", "title": "Clinical Classification" },
        { "id": "stable-angina-management", "title": "Management of Stable Angina" },
        { "id": "acs-management", "title": "Management of Acute Coronary Syndromes" },
        { "id": "secondary-prevention", "title": "Secondary Prevention" },
        { "id": "recap-drill", "title": "Management Recap Drill" },
        { "id": "exam-traps", "title": "Common Exam Traps" },
        { "id": "quick-revision", "title": "Quick Revision Summary" }
      ]
    },
    {
      "slug": "arrhythmias",
      "title": "Arrhythmias",
      "category": "Cardiovascular Disorders",
      "summary": "AF, VT, bradyarrhythmias, antiarrhythmic drug classes, and anticoagulation strategy.",
      "level": "core",
      "notePath": "arrhythmias.html",
      "tags": [
        "af",
        "atrial-fibrillation",
        "vt",
        "vaughan-williams",
        "doac",
        "warfarin",
        "amiodarone",
        "digoxin"
      ],
      "sections": [
        { "id": "what-are-arrhythmias", "title": "What Are Arrhythmias?" },
        { "id": "electrophysiology-refresher", "title": "Basic Electrophysiology Refresher" },
        { "id": "major-arrhythmias-tested", "title": "Major Arrhythmias Tested" },
        { "id": "atrial-fibrillation", "title": "Atrial Fibrillation (AF)" },
        { "id": "stroke-prevention-in-af", "title": "Stroke Prevention in AF" },
        { "id": "ventricular-arrhythmias", "title": "Ventricular Arrhythmias" },
        { "id": "bradyarrhythmias", "title": "Bradyarrhythmias" },
        { "id": "vaughan-williams-summary", "title": "Vaughan-Williams Classification Summary" },
        { "id": "management-recap-drill", "title": "Management Recap Drill" },
        { "id": "exam-traps", "title": "Common Exam Traps" },
        { "id": "quick-revision", "title": "Quick Revision Summary" }
      ]
    },
    {
      "slug": "dyslipidemia",
      "title": "Dyslipidemia",
      "category": "Cardiovascular Disorders",
      "summary": "LDL-focused risk reduction, statins, non-statin escalation, and hypertriglyceridemia strategy.",
      "level": "core",
      "notePath": "dyslipidemia.html",
      "tags": [
        "ldl",
        "ascvd",
        "statin",
        "pcsk9",
        "ezetimibe",
        "fibrate",
        "triglycerides"
      ],
      "sections": [
        { "id": "what-is-dyslipidemia", "title": "What Is Dyslipidemia?" },
        { "id": "pathophysiology", "title": "Pathophysiology" },
        { "id": "risk-assessment", "title": "Risk Assessment" },
        { "id": "first-line-therapy", "title": "First-Line Therapy" },
        { "id": "non-statin-therapy", "title": "Non-Statin Therapy" },
        { "id": "hypertriglyceridemia", "title": "Hypertriglyceridemia" },
        { "id": "treatment-strategy-summary", "title": "Treatment Strategy Summary" },
        { "id": "management-recap-drill", "title": "Management Recap Drill" },
        { "id": "exam-traps", "title": "Common Exam Traps" },
        { "id": "quick-revision", "title": "Quick Revision Summary" }
      ]
    },
    {
      "slug": "anticoagulation-vte",
      "title": "Anticoagulation & VTE",
      "category": "Hematology",
      "summary": "DVT/PE framework, DOAC-first strategy, heparins, warfarin, HIT, thrombolysis, and duration decisions.",
      "level": "core",
      "notePath": "anticoagulation-vte.html",
      "tags": [
        "vte",
        "dvt",
        "pe",
        "doac",
        "warfarin",
        "heparin",
        "hit",
        "thrombolysis"
      ],
      "sections": [
        { "id": "what-is-vte", "title": "What Is VTE?" },
        { "id": "pathophysiology", "title": "Pathophysiology" },
        { "id": "clinical-presentation", "title": "Clinical Presentation" },
        { "id": "management-overview", "title": "Management Overview" },
        { "id": "doacs", "title": "DOACs" },
        { "id": "heparins", "title": "Heparins" },
        { "id": "warfarin", "title": "Warfarin" },
        { "id": "duration-of-therapy", "title": "Duration of Therapy" },
        { "id": "pe-severity", "title": "PE Severity and Thrombolysis" },
        { "id": "special-situations", "title": "Special Situations" },
        { "id": "management-recap-drill", "title": "Management Recap Drill" },
        { "id": "exam-traps", "title": "Common Exam Traps" },
        { "id": "quick-revision", "title": "Quick Revision Summary" }
      ]
    },
    {
      "slug": "peripheral-arterial-disease",
      "title": "Peripheral Arterial Disease",
      "category": "Cardiovascular Disorders",
      "summary": "PAD diagnosis with ABI, prevention-first therapy, claudication management, and revascularization strategy.",
      "level": "core",
      "notePath": "peripheral-arterial-disease.html",
      "tags": [
        "pad",
        "claudication",
        "abi",
        "cilostazol",
        "critical-limb-ischemia",
        "antiplatelet",
        "statin"
      ],
      "sections": [
        { "id": "what-is-pad", "title": "What Is Peripheral Arterial Disease?" },
        { "id": "pathophysiology", "title": "Pathophysiology" },
        { "id": "clinical-presentation", "title": "Clinical Presentation" },
        { "id": "diagnosis", "title": "Diagnosis" },
        { "id": "management-goals", "title": "Management Goals" },
        { "id": "foundational-therapy", "title": "Foundational Therapy" },
        { "id": "symptom-improvement-therapy", "title": "Symptom Improvement Therapy" },
        { "id": "revascularization", "title": "Revascularization" },
        { "id": "antithrombotic-intensification", "title": "Antithrombotic Intensification" },
        { "id": "risk-factor-management", "title": "Risk Factor Management" },
        { "id": "management-recap-drill", "title": "Management Recap Drill" },
        { "id": "exam-traps", "title": "Common Exam Traps" },
        { "id": "quick-revision", "title": "Quick Revision Summary" }
      ]
    },
    {
      "slug": "valvular-heart-disease",
      "title": "Valvular Heart Disease",
      "category": "Cardiovascular Disorders",
      "summary": "Aortic and mitral valve lesion patterns, supportive pharmacology, intervention timing, and prosthetic valve anticoagulation.",
      "level": "core",
      "notePath": "valvular-heart-disease.html",
      "tags": [
        "vhd",
        "aortic-stenosis",
        "aortic-regurgitation",
        "mitral-regurgitation",
        "mitral-stenosis",
        "tavr",
        "prosthetic-valve",
        "warfarin"
      ],
      "sections": [
        { "id": "what-is-vhd", "title": "What Is Valvular Heart Disease?" },
        { "id": "major-valve-disorders", "title": "Major Valve Disorders" },
        { "id": "aortic-stenosis", "title": "Aortic Stenosis" },
        { "id": "aortic-regurgitation", "title": "Aortic Regurgitation" },
        { "id": "mitral-regurgitation", "title": "Mitral Regurgitation" },
        { "id": "mitral-stenosis", "title": "Mitral Stenosis" },
        { "id": "prosthetic-valves", "title": "Prosthetic Valves" },
        { "id": "endocarditis-prophylaxis", "title": "Endocarditis Prophylaxis" },
        { "id": "management-recap-drill", "title": "Management Recap Drill" },
        { "id": "exam-traps", "title": "Common Exam Traps" },
        { "id": "quick-revision", "title": "Quick Revision Summary" }
      ]
    },
    {
      "slug": "cardiomyopathies",
      "title": "Cardiomyopathies",
      "category": "Cardiovascular Disorders",
      "summary": "DCM, HCM, and RCM with high-yield pharmacology, obstruction traps, and ICD risk framework.",
      "level": "core",
      "notePath": "cardiomyopathies.html",
      "tags": [
        "dcm",
        "hcm",
        "rcm",
        "lvot",
        "icd",
        "sudden-cardiac-death",
        "heart-failure"
      ],
      "sections": [
        { "id": "what-are-cardiomyopathies", "title": "What Are Cardiomyopathies?" },
        { "id": "dilated-cardiomyopathy", "title": "Dilated Cardiomyopathy" },
        { "id": "hypertrophic-cardiomyopathy", "title": "Hypertrophic Cardiomyopathy" },
        { "id": "restrictive-cardiomyopathy", "title": "Restrictive Cardiomyopathy" },
        { "id": "sudden-cardiac-death-risk", "title": "Sudden Cardiac Death Risk" },
        { "id": "management-recap-drill", "title": "Management Recap Drill" },
        { "id": "exam-traps", "title": "Common Exam Traps" },
        { "id": "quick-revision", "title": "Quick Revision Summary" }
      ]
    },
    {
      "slug": "aortic-diseases",
      "title": "Aortic Diseases",
      "category": "Cardiovascular Disorders",
      "summary": "Aortic dissection emergency sequence, AAA/TAA surveillance, blood pressure strategy, and repair thresholds.",
      "level": "core",
      "notePath": "aortic-diseases.html",
      "tags": [
        "aortic-dissection",
        "aaa",
        "taa",
        "beta-blocker",
        "nitroprusside",
        "marfan",
        "surgical-threshold"
      ],
      "sections": [
        { "id": "what-are-aortic-diseases", "title": "What Are Aortic Diseases?" },
        { "id": "aortic-dissection", "title": "Aortic Dissection" },
        { "id": "aortic-aneurysm", "title": "Aortic Aneurysm" },
        { "id": "management-recap-drill", "title": "Management Recap Drill" },
        { "id": "exam-traps", "title": "Common Exam Traps" },
        { "id": "quick-revision", "title": "Quick Revision Summary" }
      ]
    },
    {
      "slug": "asthma",
      "title": "Asthma",
      "category": "Respiratory Disorders",
      "summary": "Inflammation-first asthma management, stepwise controller escalation, acute exacerbation treatment, and biologic selection.",
      "level": "core",
      "notePath": "asthma.html",
      "tags": [
        "asthma",
        "saba",
        "ics",
        "laba",
        "lama",
        "montelukast",
        "omalizumab",
        "mepolizumab",
        "exacerbation",
        "gina"
      ],
      "sections": [
        { "id": "what-is-asthma", "title": "What Is Asthma?" },
        { "id": "pathophysiology", "title": "Pathophysiology" },
        { "id": "classification", "title": "Classification (Adults)" },
        { "id": "saba", "title": "Short-Acting Beta Agonists (SABA)" },
        { "id": "ics", "title": "Inhaled Corticosteroids (ICS)" },
        { "id": "laba", "title": "Long-Acting Beta Agonists (LABA)" },
        { "id": "ics-laba", "title": "ICS + LABA Combination" },
        { "id": "lama", "title": "LAMA Add-On Therapy" },
        { "id": "ltra", "title": "Leukotriene Receptor Antagonists" },
        { "id": "biologics", "title": "Biologic Therapy (Severe Asthma)" },
        { "id": "acute-exacerbation", "title": "Acute Exacerbation Management" },
        { "id": "stepwise-summary", "title": "Stepwise Treatment Summary" },
        { "id": "guidelines", "title": "Guideline References" },
        { "id": "exam-traps", "title": "Common Exam Traps" },
        { "id": "quick-revision", "title": "Quick Revision Summary" },
        { "id": "practice-questions", "title": "Practice Questions" }
      ]
    },
    {
      "slug": "copd",
      "title": "COPD",
      "category": "Respiratory Disorders",
      "summary": "GOLD A/B/E treatment logic, maintenance inhaler selection, exacerbation management, and oxygen therapy criteria.",
      "level": "core",
      "notePath": "copd.html",
      "tags": [
        "copd",
        "gold",
        "lama",
        "laba",
        "ics",
        "triple-therapy",
        "roflumilast",
        "oxygen",
        "exacerbation"
      ],
      "sections": [
        { "id": "what-is-copd", "title": "What Is COPD?" },
        { "id": "pathophysiology", "title": "Pathophysiology" },
        { "id": "gold-classification", "title": "GOLD Classification (A/B/E)" },
        { "id": "rescue-bronchodilators", "title": "Short-Acting Bronchodilators" },
        { "id": "lama", "title": "Long-Acting Muscarinic Antagonists (LAMA)" },
        { "id": "laba", "title": "Long-Acting Beta Agonists (LABA)" },
        { "id": "laba-lama", "title": "LABA + LAMA Combination" },
        { "id": "ics", "title": "ICS Role in COPD" },
        { "id": "triple-therapy", "title": "Triple Therapy (ICS + LABA + LAMA)" },
        { "id": "roflumilast", "title": "PDE-4 Inhibitor (Roflumilast)" },
        { "id": "acute-exacerbation", "title": "Acute Exacerbation Management" },
        { "id": "oxygen-therapy", "title": "Oxygen Therapy Criteria" },
        { "id": "management-recap-drill", "title": "Management Recap Drill" },
        { "id": "guidelines", "title": "Guideline References" },
        { "id": "exam-traps", "title": "Common Exam Traps" },
        { "id": "quick-revision", "title": "Quick Revision Summary" },
        { "id": "practice-questions", "title": "Practice Questions" }
      ]
    },
    {
      "slug": "pneumonia",
      "title": "Pneumonia",
      "category": "Infectious Diseases",
      "summary": "CAP, HAP, and VAP empiric treatment logic with dosing, MRSA risk strategy, de-escalation, and therapy duration.",
      "level": "core",
      "notePath": "pneumonia.html",
      "tags": [
        "pneumonia",
        "cap",
        "hap",
        "vap",
        "mrsa",
        "pseudomonas",
        "ceftriaxone",
        "azithromycin",
        "levofloxacin",
        "idsa"
      ],
      "sections": [
        { "id": "what-is-pneumonia", "title": "What Is Pneumonia?" },
        { "id": "common-pathogens", "title": "Common Pathogens" },
        { "id": "cap-outpatient-no-comorb", "title": "CAP Outpatient (No Comorbidities)" },
        { "id": "cap-outpatient-comorb", "title": "CAP Outpatient (With Comorbidities)" },
        { "id": "cap-inpatient-non-icu", "title": "Inpatient CAP (Non-ICU)" },
        { "id": "cap-icu", "title": "ICU CAP" },
        { "id": "hap", "title": "Hospital-Acquired Pneumonia (HAP)" },
        { "id": "vap", "title": "Ventilator-Associated Pneumonia (VAP)" },
        { "id": "duration", "title": "Duration of Therapy" },
        { "id": "management-recap-drill", "title": "Management Recap Drill" },
        { "id": "guidelines", "title": "Guideline References" },
        { "id": "exam-traps", "title": "Common Exam Traps" },
        { "id": "quick-revision", "title": "Quick Revision Summary" },
        { "id": "practice-questions", "title": "Practice Questions" }
      ]
    },
    {
      "slug": "tuberculosis",
      "title": "Tuberculosis",
      "category": "Infectious Diseases",
      "summary": "Latent versus active TB management, RIPE therapy phases, toxicity monitoring, and drug-resistant TB overview.",
      "level": "core",
      "notePath": "tuberculosis.html",
      "tags": [
        "tuberculosis",
        "tb",
        "latent-tb",
        "active-tb",
        "ripe",
        "isoniazid",
        "rifampin",
        "ethambutol",
        "pyrazinamide",
        "mdr-tb"
      ],
      "sections": [
        { "id": "types-of-tb", "title": "Types of TB" },
        { "id": "latent-tb", "title": "Latent TB Treatment" },
        { "id": "active-tb", "title": "Active TB (RIPE Therapy)" },
        { "id": "monitoring", "title": "Monitoring During Active TB" },
        { "id": "drug-resistant-tb", "title": "Drug-Resistant TB Overview" },
        { "id": "counseling", "title": "Important Counseling Points" },
        { "id": "management-recap-drill", "title": "Management Recap Drill" },
        { "id": "guidelines", "title": "Guideline References" },
        { "id": "exam-traps", "title": "Common Exam Traps" },
        { "id": "quick-revision", "title": "Quick Revision Summary" },
        { "id": "practice-questions", "title": "Practice Questions" }
      ]
    },
    {
      "slug": "pulmonary-hypertension",
      "title": "Pulmonary Hypertension",
      "category": "Respiratory Disorders",
      "summary": "WHO group classification, Group 1 PAH targeted pathways, CTEPH strategy, and right-heart support.",
      "level": "core",
      "notePath": "pulmonary-hypertension.html",
      "tags": [
        "ph",
        "pah",
        "cteph",
        "era",
        "pde5",
        "prostacyclin",
        "riociguat"
      ],
      "sections": [
        { "id": "what-is-ph", "title": "What Is Pulmonary Hypertension?" },
        { "id": "classification", "title": "WHO Classification" },
        { "id": "pathophysiology", "title": "PAH Pathophysiology" },
        { "id": "group-1-management", "title": "Group 1 PAH Management" },
        { "id": "group-specific-management", "title": "Group-Specific Management" },
        { "id": "right-heart-failure-management", "title": "Right Heart Failure Management" },
        { "id": "management-recap-drill", "title": "Management Recap Drill" },
        { "id": "exam-traps", "title": "Common Exam Traps" },
        { "id": "quick-revision", "title": "Quick Revision Summary" }
      ]
    },
    {
      "slug": "pulmonary-embolism",
      "title": "Pulmonary Embolism (PE)",
      "category": "Respiratory Disorders",
      "summary": "Respiratory-first PE approach with risk stratification, anticoagulation pathways, thrombolysis criteria, and duration strategy.",
      "level": "core",
      "notePath": "pulmonary-embolism.html",
      "tags": [
        "pe",
        "pulmonary-embolism",
        "dvt",
        "doac",
        "heparin",
        "thrombolysis",
        "ivc-filter"
      ],
      "sections": [
        { "id": "definition", "title": "Definition" },
        { "id": "clinical-presentation", "title": "Clinical Presentation" },
        { "id": "risk-stratification", "title": "Risk Stratification" },
        { "id": "initial-anticoagulation", "title": "Initial Anticoagulation" },
        { "id": "doacs", "title": "Direct Oral Anticoagulants (DOACs)" },
        { "id": "thrombolysis", "title": "Thrombolysis (Massive PE)" },
        { "id": "duration", "title": "Duration of Anticoagulation" },
        { "id": "ivc-filter", "title": "Inferior Vena Cava (IVC) Filter" },
        { "id": "management-recap-drill", "title": "Management Recap Drill" },
        { "id": "guidelines", "title": "Guideline References" },
        { "id": "exam-traps", "title": "Common Exam Traps" },
        { "id": "quick-revision", "title": "Quick Revision Summary" },
        { "id": "practice-questions", "title": "Practice Questions" }
      ]
    },
    {
      "slug": "pericardial-diseases",
      "title": "Pericardial Diseases",
      "category": "Cardiovascular Disorders",
      "summary": "Acute pericarditis treatment, effusion/tamponade emergency handling, and constrictive pericarditis strategy.",
      "level": "core",
      "notePath": "pericardial-diseases.html",
      "tags": [
        "pericarditis",
        "colchicine",
        "nsaid",
        "tamponade",
        "beck-triad",
        "pericardiocentesis",
        "constrictive-pericarditis"
      ],
      "sections": [
        { "id": "what-are-pericardial-diseases", "title": "What Are Pericardial Diseases?" },
        { "id": "acute-pericarditis", "title": "Acute Pericarditis" },
        { "id": "pericardial-effusion", "title": "Pericardial Effusion" },
        { "id": "cardiac-tamponade", "title": "Cardiac Tamponade" },
        { "id": "constrictive-pericarditis", "title": "Constrictive Pericarditis" },
        { "id": "management-recap-drill", "title": "Management Recap Drill" },
        { "id": "exam-traps", "title": "Common Exam Traps" },
        { "id": "quick-revision", "title": "Quick Revision Summary" }
      ]
    },
    {
      "slug": "shock-cardiovascular-focus",
      "title": "Shock (Cardiovascular Focus)",
      "category": "Cardiovascular Disorders",
      "summary": "Cardiogenic and obstructive shock emphasis with vasopressor/inotrope strategy and cause-directed management.",
      "level": "core",
      "notePath": "shock-cardiovascular-focus.html",
      "tags": [
        "shock",
        "cardiogenic-shock",
        "norepinephrine",
        "dobutamine",
        "vasopressor",
        "inotrope",
        "obstructive-shock"
      ],
      "sections": [
        { "id": "what-is-shock", "title": "What Is Shock?" },
        { "id": "types-of-shock", "title": "Types of Shock" },
        { "id": "cardiogenic-shock", "title": "Cardiogenic Shock" },
        { "id": "vasopressors-and-inotropes", "title": "Vasopressors and Inotropes" },
        { "id": "cardiogenic-shock-protocol", "title": "Cardiogenic Shock Protocol" },
        { "id": "hypovolemic-shock", "title": "Hypovolemic Shock" },
        { "id": "septic-shock", "title": "Septic Shock" },
        { "id": "obstructive-shock", "title": "Obstructive Shock" },
        { "id": "management-recap-drill", "title": "Management Recap Drill" },
        { "id": "exam-traps", "title": "Common Exam Traps" },
        { "id": "quick-revision", "title": "Quick Revision Summary" }
      ]
    },
    {
      "slug": "congenital-heart-disease",
      "title": "Congenital Heart Disease",
      "category": "Cardiovascular Disorders",
      "summary": "Shunt physiology, PDA closure vs ductal maintenance, cyanotic stabilization, and Eisenmenger progression.",
      "level": "core",
      "notePath": "congenital-heart-disease.html",
      "tags": [
        "chd",
        "pda",
        "tetralogy-of-fallot",
        "cyanotic-defects",
        "alprostadil",
        "indomethacin",
        "eisenmenger"
      ],
      "sections": [
        { "id": "what-is-chd", "title": "What Is Congenital Heart Disease?" },
        { "id": "left-to-right-shunts", "title": "Left-to-Right Shunts" },
        { "id": "pda", "title": "Patent Ductus Arteriosus" },
        { "id": "keep-ductus-open", "title": "Keeping Ductus Open" },
        { "id": "cyanotic-defects", "title": "Cyanotic Defects" },
        { "id": "eisenmenger", "title": "Eisenmenger Syndrome" },
        { "id": "endocarditis-prophylaxis", "title": "Endocarditis Prophylaxis" },
        { "id": "management-recap-drill", "title": "Management Recap Drill" },
        { "id": "exam-traps", "title": "Common Exam Traps" },
        { "id": "quick-revision", "title": "Quick Revision Summary" }
      ]
    },
    {
      "slug": "diabetes-mellitus",
      "title": "Diabetes Mellitus",
      "category": "Endocrinology",
      "summary": "T1DM and T2DM diagnosis, insulin and non-insulin drug classes, DKA/HHS management, and complication prevention.",
      "level": "core",
      "notePath": "diabetes-mellitus.html",
      "tags": [
        "diabetes",
        "t1dm",
        "t2dm",
        "metformin",
        "sglt2",
        "glp1",
        "dka",
        "hhs"
      ],
      "sections": [
        { "id": "what-is-diabetes", "title": "What Is Diabetes Mellitus?" },
        { "id": "classification", "title": "Classification" },
        { "id": "diagnostic-criteria", "title": "Diagnostic Criteria" },
        { "id": "pathophysiology", "title": "Type 2 Pathophysiology" },
        { "id": "goals-of-therapy", "title": "Goals of Therapy" },
        { "id": "type-1-management", "title": "Type 1 Management" },
        { "id": "type-2-pharmacology", "title": "Type 2 Pharmacologic Therapy" },
        { "id": "acute-complications", "title": "Acute Complications" },
        { "id": "chronic-complications", "title": "Chronic Complications" },
        { "id": "management-recap-drill", "title": "Management Recap Drill" },
        { "id": "exam-traps", "title": "Common Exam Traps" },
        { "id": "quick-revision", "title": "Quick Revision Summary" }
      ]
    },
    {
      "slug": "thyroid-disorders",
      "title": "Thyroid Disorders",
      "category": "Endocrinology",
      "summary": "Hypothyroidism and hyperthyroidism diagnosis, levothyroxine and antithyroid therapy, and thyroid storm sequence.",
      "level": "core",
      "notePath": "thyroid-disorders.html",
      "tags": [
        "thyroid",
        "hypothyroidism",
        "hyperthyroidism",
        "levothyroxine",
        "methimazole",
        "ptu",
        "thyroid-storm"
      ],
      "sections": [
        { "id": "thyroid-physiology", "title": "Thyroid Physiology" },
        { "id": "hypothyroidism", "title": "Hypothyroidism" },
        { "id": "hypothyroidism-management", "title": "Hypothyroidism Management" },
        { "id": "myxedema-coma", "title": "Myxedema Coma" },
        { "id": "hyperthyroidism", "title": "Hyperthyroidism" },
        { "id": "hyperthyroidism-management", "title": "Hyperthyroidism Management" },
        { "id": "thyroid-storm", "title": "Thyroid Storm" },
        { "id": "subclinical-disease", "title": "Subclinical Thyroid Disease" },
        { "id": "management-recap-drill", "title": "Management Recap Drill" },
        { "id": "exam-traps", "title": "Common Exam Traps" },
        { "id": "quick-revision", "title": "Quick Revision Summary" }
      ]
    },
    {
      "slug": "adrenal-disorders",
      "title": "Adrenal Disorders",
      "category": "Endocrinology",
      "summary": "Cortisol excess/deficiency patterns, adrenal crisis emergency therapy, and hyperaldosteronism management.",
      "level": "core",
      "notePath": "adrenal-disorders.html",
      "tags": [
        "adrenal",
        "cushing",
        "addison",
        "adrenal-crisis",
        "hyperaldosteronism",
        "spironolactone",
        "hydrocortisone"
      ],
      "sections": [
        { "id": "adrenal-physiology", "title": "Adrenal Physiology" },
        { "id": "cushing-syndrome", "title": "Cushing Syndrome" },
        { "id": "addison-disease", "title": "Addison Disease" },
        { "id": "adrenal-crisis", "title": "Adrenal Crisis" },
        { "id": "secondary-adrenal-insufficiency", "title": "Secondary Adrenal Insufficiency" },
        { "id": "primary-hyperaldosteronism", "title": "Primary Hyperaldosteronism" },
        { "id": "management-recap-drill", "title": "Management Recap Drill" },
        { "id": "exam-traps", "title": "Common Exam Traps" },
        { "id": "quick-revision", "title": "Quick Revision Summary" }
      ]
    },
    {
      "slug": "pituitary-disorders",
      "title": "Pituitary Disorders",
      "category": "Endocrinology",
      "summary": "Prolactinoma and acromegaly therapy plus DI and SIADH water-balance management.",
      "level": "core",
      "notePath": "pituitary-disorders.html",
      "tags": [
        "pituitary",
        "prolactinoma",
        "acromegaly",
        "diabetes-insipidus",
        "siadh",
        "desmopressin",
        "tolvaptan"
      ],
      "sections": [
        { "id": "pituitary-physiology", "title": "Pituitary Physiology" },
        { "id": "prolactinoma", "title": "Prolactinoma" },
        { "id": "acromegaly", "title": "Acromegaly" },
        { "id": "diabetes-insipidus", "title": "Diabetes Insipidus" },
        { "id": "siadh", "title": "SIADH" },
        { "id": "management-recap-drill", "title": "Management Recap Drill" },
        { "id": "exam-traps", "title": "Common Exam Traps" },
        { "id": "quick-revision", "title": "Quick Revision Summary" }
      ]
    },
    {
      "slug": "parathyroid-calcium-disorders",
      "title": "Parathyroid and Calcium Disorders",
      "category": "Endocrinology",
      "summary": "PTH-driven calcium regulation, hyper/hypoparathyroidism, and acute calcium disorder treatment strategies.",
      "level": "core",
      "notePath": "parathyroid-calcium-disorders.html",
      "tags": [
        "parathyroid",
        "calcium",
        "hyperparathyroidism",
        "hypoparathyroidism",
        "hypercalcemia",
        "hypocalcemia",
        "cinacalcet"
      ],
      "sections": [
        { "id": "calcium-physiology", "title": "Calcium Physiology" },
        { "id": "hyperparathyroidism", "title": "Hyperparathyroidism" },
        { "id": "hypoparathyroidism", "title": "Hypoparathyroidism" },
        { "id": "hypercalcemia", "title": "Hypercalcemia" },
        { "id": "hypocalcemia", "title": "Hypocalcemia" },
        { "id": "management-recap-drill", "title": "Management Recap Drill" },
        { "id": "exam-traps", "title": "Common Exam Traps" },
        { "id": "quick-revision", "title": "Quick Revision Summary" }
      ]
    },
    {
      "slug": "osteoporosis-bone-metabolism",
      "title": "Osteoporosis and Bone Metabolism",
      "category": "Endocrinology",
      "summary": "Fracture-risk treatment strategy with bisphosphonate first-line therapy and anabolic alternatives.",
      "level": "core",
      "notePath": "osteoporosis-bone-metabolism.html",
      "tags": [
        "osteoporosis",
        "bisphosphonate",
        "denosumab",
        "teriparatide",
        "romosozumab",
        "raloxifene",
        "glucocorticoid-induced"
      ],
      "sections": [
        { "id": "definition", "title": "Definition" },
        { "id": "risk-factors", "title": "Risk Factors" },
        { "id": "treatment-overview", "title": "Treatment Overview" },
        { "id": "calcium-vitamin-d", "title": "Calcium and Vitamin D" },
        { "id": "bisphosphonates", "title": "Bisphosphonates" },
        { "id": "denosumab", "title": "Denosumab" },
        { "id": "teriparatide", "title": "Teriparatide" },
        { "id": "romosozumab", "title": "Romosozumab" },
        { "id": "serms", "title": "SERMs" },
        { "id": "glucocorticoid-induced", "title": "Glucocorticoid-Induced Osteoporosis" },
        { "id": "management-recap-drill", "title": "Management Recap Drill" },
        { "id": "exam-traps", "title": "Common Exam Traps" },
        { "id": "quick-revision", "title": "Quick Revision Summary" }
      ]
    },
    {
      "slug": "reproductive-endocrinology",
      "title": "Reproductive Endocrinology",
      "category": "Women's & Men's Health",
      "summary": "PCOS, HRT, contraceptive pharmacology, male hypogonadism, and erectile dysfunction treatment pathways.",
      "level": "core",
      "notePath": "reproductive-endocrinology.html",
      "tags": [
        "pcos",
        "hrt",
        "contraception",
        "hypogonadism",
        "erectile-dysfunction",
        "sildenafil",
        "testosterone"
      ],
      "sections": [
        { "id": "pcos", "title": "Polycystic Ovary Syndrome" },
        { "id": "menopause-hrt", "title": "Menopause and HRT" },
        { "id": "hormonal-contraceptives", "title": "Hormonal Contraceptives" },
        { "id": "male-hypogonadism", "title": "Male Hypogonadism" },
        { "id": "erectile-dysfunction", "title": "Erectile Dysfunction" },
        { "id": "management-recap-drill", "title": "Management Recap Drill" },
        { "id": "exam-traps", "title": "Common Exam Traps" },
        { "id": "quick-revision", "title": "Quick Revision Summary" }
      ]
    }
  ]
}
